@article{d03740134cab4ad8b867a26d13c01ca6,
title = "Generic MS medications: Reducing costs without compromising safety",
author = "Schorr, {Emily M.} and Calabresi, {Peter A.}",
note = "Funding Information: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: E.M.S. has received fellowship funding from Biogen. P.A.C. is PI on a research grant from Genentech, and previously Annexon, to Johns Hopkins University. He has received personal consulting fees from Lilly, Biogen, Idorsia, Nervgen, and Vaccitech for serving as a scientific advisor on preclinical development projects. ",
year = "2022",
month = dec,
doi = "10.1177/13524585221135129",
language = "English",
volume = "28",
pages = "2157--2159",
journal = "Multiple Sclerosis Journal",
issn = "1352-4585",
publisher = "SAGE Publications Ltd",
number = "14",
}